The influence of sprint training on endogenous urinary purine loss was examined in 7 active male subjects (age, 23.1 ± 1.8 y; body mass, 76.1 ± 3.1 kg; VO 2 peak , 56.3 ± 4.0 mLÁkg -1 Ámin -1 ). Each subject performed a 30 s sprint performance test (PT), before and after 7 d of sprint training. Training consisted of 15 sprints, each lasting 10 s, on an air-braked cycle ergometer performed twice each day. A rest period of 50 s separated each sprint during training. Sprint training resulted in a 20% higher muscle ATP immediately after PT, a lower IMP (57% and 89%, immediately after and 10 min after PT, respectively), and inosine accumulation (53% and 56%, immediately after and 10 min after the PT, respectively). Sprint training also attenuated the exercise-induced increases in plasma inosine, hypoxanthine (Hx), and uric acid during the first 120 min of recovery and reduced the total urinary excretion of purines (inosine + Hx + uric acid) in the 24 h recovery period following intense exercise. These results show that intermittent sprint training reduces the total urinary purine excretion after a 30 s sprint bout.
Introduction
The ATP content of untrained human skeletal muscle is about 20-25 mmolÁkg -1 dry mass (d.m.) , and several reports have demonstrated that intense intermittent sprint training can lower the resting content by as much as 20% (HellstenWesting et al. 1993a; Stathis et al. 1994; Hellsten et al. 2004) . The factors responsible for the set point of resting muscle adenine nucleotide (AdN = ATP + ADP + AMP) content are unknown; however, it is influenced by the balance between loss of purine base from the muscle and its production via de novo purine synthesis. Intense exercise results in a transient reduction of ATP and concomitant accumulation of IMP (Stathis et al. 1994 ). Most of this IMP is rapidly resynthesised to ATP during recovery, although a small portion is further degraded and results in the production of the purine bases inosine and hypoxanthine (Hx; Stathis et al. 1994) . Purine bases, not recovered intramuscularly via purine salvage, efflux the muscle (Hellsten et al. 1999 ) and accumulate in the plasma (Bangsbo et al. 1992; Tullson et al. 1995; Stathis et al. 1999) . Once in the plasma, purine bases are not recovered by skeletal muscle (Hellsten et al. 1999) . The magnitude of purine loss can be between 5% and 9% of the resting muscle ATP content (Bangsbo et al. 1992; Hellsten et al. 1999) . It has been reported that the plasma purines are excreted in the urine (Nasrallah and Al Khalidi 1964; Sutton et al. 1980; Stathis et al. 1999 ), or converted to uric acid (Hellsten-Westing et al. 1994 ) and subse-quently excreted (Nasrallah and Al Khalidi 1964; Sorensen and Levinson 1975; Stathis et al. 1999 ). Sorensen and Levinson (1975) demonstrated that, in a resting individual, the uric acid loss via the gut is one third, whereas via the urine it is two thirds of the total uric acid loss of an untrained individual.
Exercise intensity and duration can influence the plasma purine accumulation in recovery (Sjodin and Hellsten-Westing 1990; Hellsten et al. 1999) , as does the frequency and number of intermittent sprint bouts (Balsom et al. 1992a; Balsom et al. 1992b; Stathis et al. 1999) . The number of repetitions in a sprint challenge also influences the excretion of urinary purines during recovery (Stathis et al. 1999) .
Sprint training reduces the accumulation of IMP (Stathis et al. 1994; Harmer et al. 2000; Parra et al. 2000) and inosine (Stathis et al. 1994) in the muscle following an intense sprint. Furthermore, sprint training attenuates the plasma inosine, Hx, and uric acid accumulation during recovery from an intense exercise bout (Stathis et al. 1994) . However, the effect of sprint training on urinary purine excretion following a maximal sprint bout is unknown.
The aim of this study was to investigate the effects of an intense 7 d sprint training program on the loss of endogenous purine metabolites in the urine during recovery from an intense sprint bout. It was hypothesized that sprint training will reduce the accumulation of muscle IMP and inosine during a 30 s sprint bout and attenuate the concentration of plasma purine metabolites, i.e., inosine, Hx, and uric acid, during recovery from a 30 s sprint bout, consistent with previous studies. This will lead to a reduction in urinary excretion of purine metabolites during recovery from the sprint.
Materials and methods

Subjects
Seven active, non-specifically trained males (age, 23.1 ± 1.8 y; body mass, 76.1 ± 3.1 kg; VO 2 peak , 56.3 ± 4.0 mLÁkg -1 Ámin -1 ), volunteered for the study, which was approved by the Victoria University Human Research Ethics Committee. All subjects were fully informed of the experimental procedures and voluntarily consented to take part in the study.
Peak oxygen consumption (VO 2 peak )
The VO 2 peak of each subject was determined approximately 1 week before the beginning of the experimental trials. The exercise protocol involved riding on a cycle ergometer (Lode, Groningen, The Netherlands) for 3 min at 3 submaximal work rates, after which the work rate was increased every minute thereafter until volitional exhaustion. Expired air was directed by a Hans Rudolph valve through a ventilometer (Pneumoscan S30, KL engineering, Melbourne, Australia) into a mixing chamber and analysed for oxygen and carbon dioxide content by gas analysers (Applied Electrochemistry S-3A O 2 and CD-3A CO 2 , Ametek, Pittsburgh, Penn.). These analysers were calibrated before each test using commercially prepared gas mixtures. Oxygen consumption was calculated by a microprocessor using standard equations.
Sprint testing protocol
Performance tests (PT) were 30 s maximal sprints completed before and after a training regime. These were performed on an air-braked cycle ergometer, modified to enable computerized determination of peak power and mean power. Fatigue index (FI) was calculated using the following equation:
FI ¼ ½ðpeak power À peak power at 30 sÞ Â ðpeak powerÞ À1 Â 100
The power output of the air-braked cycle ergometer is approximately proportional to the cube of the wheel velocity, which was measured using a tachometer (Hall-effect device and a cog at the wheel hub). The subjects were instructed to remain seated and pedal as fast as possible for the 30 s exercise periods. Subjects were familiarized with the sprint task at least 1 week prior to the PT. The final PT was performed at least 24 h and less than 36 h after the last training session. The subjects were also instructed to refrain from strenuous exercise and caffeine and alcohol consumption for 24 h before the PT. In addition, subjects recorded their diet for the 24 h before the first PT and were asked to consume similar foods before the final PT. All PTs were conducted in the morning after an overnight fast. During the first 15 min of recovery from each PT the subjects ingested 500 mL of water. Subjects were also provided with food (snack bar, fruit juice, and salad sandwich) after 2 h recovery in each trial and were restricted from any other food intake until after an 8 h urine sample was obtained.
Training protocol
Sprint training was performed twice per day for 1 week and each session was separated by at least 6 h. A training session involved 15 Â 10 s maximal cycling bouts on an air-braked cycle ergometer with 50 s of rest between bouts.
Blood and urine sampling, treatment, and analysis
Blood was sampled from an antecubital vein, via an indwelling catheter, at rest, and after 0, 10, 15, 20, 30, 60, and 120 min of passive recovery from the PT. The blood was immediately placed into lithium heparin tubes and spun in a centrifuge. Subsequently, 100 mL of plasma were added to 200 mL of ice-cold 3 mol/L perchloric acid, spun, and the supernatant stored at -80 8C before analysis for lactate. Plasma lactate was determined in duplicate, using an enzymatic spectrophotometric technique (Lowry and Passoneau 1972) . The remaining plasma was stored in liquid nitrogen for analysis of inosine, Hx, and uric acid. The plasma stored for these metabolites was deproteinised with 1.5 mol/L perchloric acid and subsequently neutralized with 2.1 mol/L potassium hydrogencarbonate immediately before analysis. Plasma Hx, inosine, and uric acid were determined on neutralized perchloric acid extracts, using a modification of the reverse-phase high-performance liquid chromatography (HPLC) technique described by Wynants and Van Belle (1985) . Separation was achieved using a Merck Hibar Lichrosphere 100 CH-18/2 250 mm Â 4 mm column with the use of a Waters chromatography workstation.
Urine was collected for 12 h before the PT and for the first 2, and the subsequent 6 and 16 h periods after the PT. Urine volume was determined and an aliquot of the samples was stored at -80 8C before analysis. Samples were deproteinised, neutralized, and analyzed for inosine, Hx, and xan-thine using the same sample treatment and HPLC procedures as described for plasma. Urinary uric acid concentration was determined by an enzymatic colorimetric method using a Beckman Synchron CX 1 system. Exercise-induced endogenous urinary purine excretion was determined by calculating the difference in excretion rate during recovery from the PT, relative to the pre-PT basal excretion rate.
Muscle sampling treatment and analysis
Muscle biopsies were obtained from the vastus lateralis under local anasthesia (1% xylocaine) using the percutaneous needle biopsy technique. Muscle was sampled from the same leg from separate incisions at rest, immediately after exercise, and 10 min into recovery. Leg selection was random, with the contralateral leg biopsied in the second PT . Muscle samples were frozen in liquid nitrogen within 5 s of obtaining biopsies. Samples were weighed at -30 8C and freeze-dried, weighed, dissected free of any connective tissue, powdered, and extracted according to the method of Harris et al. (1974) . The neutralized extract was assayed enzymatically for phosphocreatine (PCr), creatine (Cr), and lactate by fluorometric analyses (Lowry and Passoneau 1972) . Reverse-phase HPLC was used to quantify ATP, ADP, AMP, IMP, inosine, and Hx concentrations using the method of Wynants and Van Belle (1985) with the same apparatus as described for plasma analysis. Muscle ATP, ADP, AMP, IMP, Cr, and PCr were adjusted to the peak total Cr content for each subject in each PT for pre-and post-training trials.
Statistical analysis
All values are reported as means ± SE. Where appropriate, the metabolite and performance data were analysed using analysis of variance (ANOVA) with repeated measures (BMDP statistical software). Simple main effects analyses and Newman-Kuels post hoc tests were used to locate differences when ANOVA revealed a significant interaction. Comparison of performance variables, total Cr content, and urinary purine loss during recovery were analysed using paired-sample t tests. The level of probability to reject the null hypothesis was set at p 0.05.
Results
Performance variables
No change in the peak power (1085.1 ± 40.3 W vs. 1081.7 ± 38 W; untrained vs. trained), mean power (617.9 ± 20.4 W vs. 630.4 ± 10.1 W), or fatigue index (58.9% ± 1.6% vs. 57.5% ± 1.4%) was observed with sprint training.
Muscle metabolites
The muscle metabolite contents at rest, immediately after exercise, and 10 min into recovery are summarized in Table 1. No differences were observed with resting muscle metabolites before and after training. The resting ATP levels showed a tendency to be lower after training using different analytical methods (p = 0.06 and 0.13, enzymatic and HPLC methods, respectively). Exercise decreased muscle ATP in both the pre-and post-training PT, but the levels upon termination of exercise were significantly higher in the posttrained compared with the pre-trained state (Table 1) . Concomitantly, sprint exercise resulted in an accumulation of IMP and inosine; however, end-exercise IMP and inosine were lower (p < 0.05) with training ( Table 1 ). The PCr, Cr, and lactate levels after exercise were unaffected by training.
The ATP content was partially restored 10 min into recovery from post-exercise values, but was still lower than pre-exercise amounts, irrespective of training status. Additionally, the levels of ATP at 10 min recovery were not different between trials. Similarly, the IMP content reduced during recovery, but did not return to resting levels in either trained ot untrained states at 10 min. Muscle inosine continued to increase during recovery in both trials; however, the content was lower post-training compared with pre-training ( Table 1) . The PCr and Cr levels at 10 min recovery after training were not different to pre-exercise levels, whereas they were significantly lower and higher, respectively, than resting levels in the untrained state. Muscle lactate levels dur- ing recovery were not affected by training. Muscle ADP and AMP were not different after PT and 10 min recovery and were not different across training. Mean total Cr was higher in the post-trained state (123.1 ± 5.2 vs. 131.5 ± 6.4 mmolÁ(kg dry mass) -1 ; p < 0.05, untrained vs. trained, respectively).
Plasma metabolite concentrations
The resting concentration of all measured metabolites were similar pre-and post-training (Fig. 1) . Training resulted in significantly lower levels of inosine in the 15-30 min (Fig. 1A) and Hx in the 15-60 min (Fig. 1B) period of recovery, whereas uric acid was lower in the trained state from 60 min to the end of measurement (120 min; Fig. 1C ). Plasma lactate was not different at any point of time during recovery in the trained state (data not shown).
Urinary excretion
Urinary excretion of inosine, Hx, and uric acid was elevated during the first 2 h period after exercise. It should be noted that there was a reduction in inosine excretion in the trained state compared with the untrained state after 2 h ( Fig. 2A) and a lower uric acid excretion in the 24 h recovery period following PT in the trained state (Fig. 2B) . Total endogenous purine metabolite (inosine + Hx + uric acid) excretion was not different in the first 2 h ( Fig. 2A ; 775 ± 133 mmol vs. 739 ± 108 mmol, untrained vs. trained). However, there was a tendency (p = 0.12) for an attenuated excretion with training after 8 h recovery, (not shown; 1378 ± 213 mmol vs. 981 ± 141 mmol, respectively) and a reduced (p < 0.05) excretion in the 24 h recovery period (1603 ± 267 mmol vs. 1237 ± 264 mmol, untrained vs. trained; Fig. 2B ). 
Discussion
Sprint training reduced the muscle (Table 1) and plasma purine concentrations (Fig. 1 ) and the excretion of urinary purines during recovery from a 30 s sprint bout (Fig. 2) . This reduction likely represents a training-induced adaptation to minimize the loss of purines from skeletal muscle. Such an adaptation is advantageous in reducing the subsequent metabolic cost of AdN replacement by the purine de novo biosynthesis pathway.
As expected, sprint training reduced the extent of ATP degradation (44.6%) and accumulation of IMP and inosine (56.7% and 66%, respectively) in the muscle during a 30 s sprint. A similar finding has been reported in other studies (Stathis et al. 1994; Harmer et al. 2000; Parra et al. 2000) and demonstrates an improved balance between the rates of ATP degradation and resynthesis with sprint training. Assuming any contribution of altered exercise efficiency is likely minimal, the rate of ATP degradation during the PT is likely to be the same, as the peak and mean power values did not differ pre-and post-training. Thus, a more likely explanation is a training-induced improvement in the rephosphorylation rate of ATP, either through anaerobic or aerobic sources.
The magnitude of PCr degradation during the PT was not significantly different after training, indicating that it does not contribute to an enhanced ATP resynthesis rate. Other contributing factors to ATP resynthesis include anaerobic glycolysis and oxidative phosphorylation. There is evidence of increased enzymatic activities of anaerobic glycolysis (phosphofructokinase and aldolase) with sprint training (Parra et al. 2000) , which could contribute to improved ADP rephosphorylation. However, the present data indicate that anaerobic glycolysis was not likely to contribute to the improved ATP resynthesis rates following sprint training, as the muscle lactate accumulation (Table 1 ) and the plasma lactate recovery profiles were not significantly different with training (data not shown). An increasing body of evidence suggests there is an increase in the oxidative potential of skeletal muscle after sprint training (Parra et al. 2000; Burgomaster et al. 2005) . Clearly, no oxygen consumption or muscle aerobic enzyme activity were measured in the current study, therefore we are unable to provide any evidence to support the notion that aerobic metabolism was enhanced in the sprint-trained state. The tempered accumulation of IMP observed during the PT with sprint training (Table 1 ) must be due to a reduced flux through AMP deaminase (AMPd) or an increased activity of pathways using IMP. Although it is not clear how the different modulators influence AMPd during intense exercise, in vitro studies have demonstrated increases in AMPd activity with elevated substrate availability (Raggi and Ranieri-Raggi 1987) and increased concentrations of ADP, AMP, and H + (Wheeler and Lowenstein 1979; Lowenstein 1990 ). Inhibition of AMPd occurs with elevated orthophosphate, ATP, and guanosine 5'-triphosphate (GTP; Wheeler and Lowenstein 1979; Lowenstein 1990) , hence a reduced net production of AMP with the aforementioned improvement in the balance between ATP hydrolysis and ATP resynthesis rates best explains the reduced IMP accumulation after the sprint training (Table 1) . Other factors that influence AMPd activity, such as PCr content (Rush et al. 1998) , are unlikely to play a role in the reduced AMPd activity in the trained state, as the PCr content in mixed muscle was the same at the end point of exercise in the PT (Table 1) . Furthermore, the attenuated accumulation of IMP observed after the PT during sprint training is not likely due to increased degradation of IMP to inosine or reamination to AMP via purine nucleotide activity. A small but significant sprint-trained reduction in inosine content after the PT (Table 1) indicates that an elevated degradation of IMP to inosine is unlikely. Evidence from rodent muscle demonstrates that the purine nucleotide cycle (PNC) does not operate in muscles contracting during high-intensity exercise (Meyer and Terjung 1980) . Furthermore, sprint training attenuated plasma inosine, Hx, and uric acid concentrations during the first 2 h of recovery after the sprint (Fig. 2) . Lower plasma Hx following training has been reported in an earlier training study (Stathis et al. 1994) and is best explained by a reduction in the magnitude of purine efflux from the muscle, although no experimental evidence is available to confirm this possibility.
Urinary purine excretion in the 24 h after PT was reduced after sprint training (Fig. 2B ) and is best explained by a decreased delivery of purine to the kidney due to lower plasma purine concentration. Attenuated plasma purine is a likely result of lower muscle purine base production and efflux into the plasma. The lower urinary purine excretion may also be influenced by a training-induced change in the loss of purines via the gut (Sorensen and Levinson 1975) . Sorensen and Levinson (1975) demonstrated that in normal untrained individuals one third of basal uric acid excretion occurs via the gut and, as yet, no studies have investigated the influence of intense exercise and (or) sprint training on this avenue of purine loss.
Previous studies have reported reduced resting muscle ATP after sprint training (Hellsten-Westing et al. 1993a; Stathis et al. 1994; Hellsten et al. 2004) . A significant reduction in resting ATP following a similar training protocol to that used in this study was achieved with 9 (Hellsten-Westing et al. 1993a ) and 8 (Hellsten et al. 2004 ) participants. The current study demonstrates a strong tendency for lower resting ATP levels in the muscle after sprint training (Table 1 ; p = 0.06 and 0.13, enzymatic and HPLC analysis, respectively). A greater number of participants will be required to clarify the situation, as the statistical power of the test for detecting a significant decrease is low in the present study (i.e., 38%), indicating that a type 2 error is likely. The imbalance between ATP loss and its resynthesis and (or) synthesis is considered responsible for the reduction in resting muscle ATP content. Assuming the elevation in purine excretion during recovery represents the loss of endogenous purines from the active muscle, the loss of purine metabolites in 24 h recovery from an intense sprint bout represents around 2% of the resting ATP content in the untrained and trained state. This was estimated by calculating the extent of purine excretion relative to the active muscle. If skeletal muscle is 40% of body mass (76.1 kg) and the legs comprise 55% of the total muscle mass (Snyder et al. 1975) , then the mean mass of the exercising muscle (both legs) is 3.85 kg d.m. (assuming 23% dry mass). The urinary purine loss is probably an underestimate, as uric acid can also cross into the gut (Sorensen and Levinson 1975) . As well as reducing the production of purines in the muscle, the conservation of muscle purine nucleotides with sprint training could also be enhanced by an increased capacity of intramuscular purine recovery after sprint training. Evidence of an elevated activity of the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase (HGPRT) after sprint training (Hellsten-Westing et al. 1993b ) supports this possibility and provides a mechanism to further reduce the loss of purines from the muscle following exercise in the trained state.
Interestingly, 7 d of intense sprint training resulted in no differences in mean power, peak power, or the fatigue index during a 30 s maximal sprint cycle bout. These results are consistent with those reported after a similar training protocol (Hellsten-Westing et al. 1993a ). The training protocol may limit any performance improvement because there is inadequate recovery time between sessions to produce optimal training adaptation. In support of this, Parra et al. (2000) demonstrated that a training programme using the same training load, but over a longer duration improved performance in a 30 s sprint test.
In conclusion, the present study demonstrated that sprint training reduced purine base accumulation in the muscle and plasma, and decreased urinary excretion of endogenous purines (inosine, Hx, and uric acid) after maximal sprint exercise. An attenuated loss of muscle purine nucleotide degradation products after a sprint bout reduces the extent of replacement of the muscle nucleotide pool via the metabolically expensive purine de novo synthesis pathway.
